Transgenomic Gross Margin 2010-2023 | PRPO
Transgenomic Gross Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM Gross Profit | Gross Margin |
2023-09-30 | $0.01B | $0.01B | 35.71% |
2023-06-30 | $0.01B | $0.00B | 27.27% |
2023-03-31 | $0.01B | $0.00B | 33.33% |
2022-12-31 | $0.01B | $0.00B | 37.50% |
2022-09-30 | $0.01B | $0.00B | 37.50% |
2022-06-30 | $0.01B | $0.00B | 50.00% |
2022-03-31 | $0.01B | $0.00B | 50.00% |
2021-12-31 | $0.01B | $0.00B | 37.50% |
2021-09-30 | $0.01B | $0.00B | 25.00% |
2021-06-30 | $0.01B | $0.00B | 12.50% |
2021-03-31 | $0.01B | 0 | 0.00% |
2020-12-31 | $0.01B | 0 | 0.00% |
2020-09-30 | $0.01B | 0 | 0.00% |
2020-06-30 | $0.00B | 0 | 0.00% |
2020-03-31 | $0.00B | 0 | 0.00% |
2019-12-31 | $0.00B | 0 | 0.00% |
2019-09-30 | $0.00B | 0 | 0.00% |
2019-06-30 | $0.00B | 0 | 0.00% |
2019-03-31 | $0.00B | 0 | 0.00% |
2018-12-31 | $0.00B | 0 | 0.00% |
2018-09-30 | $0.00B | 0 | 0.00% |
2018-06-30 | $0.00B | 0 | 0.00% |
2018-03-31 | $0.00B | 0 | 0.00% |
2017-12-31 | $0.00B | 0 | 0.00% |
2017-09-30 | $0.00B | $0.00B | 100.00% |
2017-06-30 | $0.00B | $0.00B | 100.00% |
2017-03-31 | $0.00B | $0.00B | 50.00% |
2016-12-31 | $0.00B | $0.00B | 50.00% |
2016-09-30 | $0.00B | 0 | 0.00% |
2016-06-30 | $0.00B | 0 | 0.00% |
2016-03-31 | $0.00B | 0 | nan% |
2015-12-31 | $0.00B | 0 | 0.00% |
2015-09-30 | $-0.02B | $-0.01B | 53.33% |
2015-06-30 | $-0.01B | $-0.01B | 54.55% |
2015-03-31 | $-0.00B | $-0.00B | 100.00% |
2014-12-31 | $0.00B | $-0.00B | -200.00% |
2014-09-30 | $0.02B | $0.01B | 34.78% |
2014-06-30 | $0.03B | $0.01B | 30.77% |
2014-03-31 | $0.03B | $0.01B | 34.62% |
2013-12-31 | $0.03B | $0.01B | 37.04% |
2013-09-30 | $0.03B | $0.01B | 35.71% |
2013-06-30 | $0.03B | $0.01B | 41.38% |
2013-03-31 | $0.03B | $0.01B | 45.16% |
2012-12-31 | $0.03B | $0.01B | 45.16% |
2012-09-30 | $0.03B | $0.02B | 51.52% |
2012-06-30 | $0.03B | $0.02B | 51.52% |
2012-03-31 | $0.03B | $0.02B | 53.13% |
2011-12-31 | $0.03B | $0.02B | 56.25% |
2011-09-30 | $0.03B | $0.02B | 53.57% |
2011-06-30 | $0.02B | $0.01B | 54.17% |
2011-03-31 | $0.02B | $0.01B | 47.62% |
2010-12-31 | $0.02B | $0.01B | 47.37% |
2010-09-30 | $0.02B | $0.01B | 47.62% |
2010-06-30 | $0.02B | $0.01B | 50.00% |
2010-03-31 | $0.02B | $0.01B | 54.55% |
2009-12-31 | $0.02B | $0.01B | 54.55% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.009B | $0.009B |
Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. Precipio Inc., formerly known as Transgenomic Inc., is based in Omaha, United States of America. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
GE HealthCare Technologies (GEHC) | United States | $41.123B | 22.92 |
Inspire Medical Systems (INSP) | United States | $6.468B | 0.00 |
10x Genomics (TXG) | United States | $4.396B | 0.00 |
IRhythm Technologies (IRTC) | United States | $3.586B | 0.00 |
Axonics (AXNX) | United States | $3.514B | 0.00 |
Enovis (ENOV) | United States | $3.425B | 26.02 |
Hims & Hers Health (HIMS) | United States | $3.372B | 0.00 |
Azenta (AZTA) | United States | $3.314B | 270.14 |
Olink Holding AB (publ) (OLK) | Sweden | $2.934B | 0.00 |
Privia Health (PRVA) | United States | $2.318B | 102.89 |
Schrodinger (SDGR) | United States | $1.926B | 0.00 |
Phreesia (PHR) | United States | $1.375B | 0.00 |
Omnicell (OMCL) | United States | $1.343B | 32.85 |
Definitive Healthcare (DH) | United States | $0.931B | 0.00 |
Standard BioTools (LAB) | United States | $0.780B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.646B | 0.00 |
Talkspace (TALK) | United States | $0.603B | 0.00 |
Health Catalyst (HCAT) | United States | $0.436B | 0.00 |
Clover Health Investments (CLOV) | United States | $0.393B | 0.00 |
Pulmonx (LUNG) | United States | $0.351B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.343B | 0.00 |
P3 Health Partners (PIII) | United States | $0.319B | 0.00 |
American Well (AMWL) | United States | $0.249B | 0.00 |
Butterfly Network (BFLY) | United States | $0.221B | 0.00 |
Augmedix (AUGX) | United States | $0.197B | 0.00 |
TruBridge (TBRG) | United States | $0.139B | 5.97 |
Outset Medical (OM) | United States | $0.111B | 0.00 |
MSP Recovery (LIFW) | United States | $0.097B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.091B | 0.00 |
111 (YI) | China | $0.084B | 0.00 |
Future Health ESG (FHLT) | United States | $0.064B | 0.00 |
Zepp Health (ZEPP) | China | $0.063B | 0.00 |
HeartBeam (BEAT) | United States | $0.058B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.044B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.041B | 0.00 |
Cue Health (HLTH) | United States | $0.029B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.027B | 0.00 |
Akili (AKLI) | United States | $0.023B | 0.00 |
Movano (MOVE) | United States | $0.022B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.021B | 0.00 |
ETAO (ETAO) | United States | $0.020B | 0.00 |
CareCloud (CCLD) | United States | $0.019B | 0.00 |
Centogene (CNTG) | Germany | $0.019B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.016B | 0.00 |
Syra Health (SYRA) | United States | $0.014B | 0.00 |
Biotricity (BTCY) | United States | $0.013B | 0.00 |
Predictive Oncology (POAI) | United States | $0.011B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
Heart Test Laboratories (HSCS) | United States | $0.008B | 0.00 |
Zhongchao (ZCMD) | China | $0.002B | 0.00 |
Motus GI Holdings (MOTS) | United States | $0.002B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |